Winton Group’s 10x Genomics TXG Stock Holding History

Winton Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,830	Closed	-$1.58M	–	1401
2021 Q3	$1.58M	Sell	10,830 -1,426	-12%	-$245K	0.09%	289
2021 Q2	$2.4M	Buy	+12,256	New	+$2.22M	0.13%	125
2020 Q4	–	Sell	-25,005	Closed	-$3.12M	–	1511
2020 Q3	$3.12M	Buy	+25,005	New	+$2.62M	0.1%	311

Other funds holding TXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Winton Group's TXG Position: Q4 2021 in Review

Winton Group sold out of 10x Genomics (TXG) in Q4 2021, closing a stake of 10,830 shares — an estimated $1.58M sold.

Winton Group first reported a position in TXG in Q3 2020 and held it in 3 quarters. The position peaked at $3.12M in Q3 2020. 365 funds tracked by Wall St. Rank hold TXG as of Q4 2021.

Winton Group reported no remaining 10x Genomics position as of Q4 2021 after selling out during the quarter.
Winton Group sold 10,830 10x Genomics shares in Q4 2021, an estimated $1.58M.
Winton Group first reported a position in 10x Genomics in Q3 2020 and held it in 3 quarters.
Winton Group's 10x Genomics position peaked at $3.12M in Q3 2020.
365 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.